课题基金 / 基金详情

SGER: Biophotonics: Nano-based Contrast Agent for Molecular Optical-based Imaging of Prostate Cancer

SGER: Biophotonics: Nano-based Contrast Agent for Molecular Optical-based Imaging of Prostate Cancer
SGER:生物光子学:用于前列腺癌分子光学成像的纳米造影剂
批准号:
0632281
负责人:
Massoud Motamedi
金额:
$0.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-06-15 至 2009-08-31

项目摘要

项目成果

Massoud Motamedi的其他基金

相似基金

相关文献

中文摘要
翻译
申请人建议通过用适体使纳米金颗粒功能化来增强前列腺癌的靶向性,该适体将特异性地与前列腺特异性膜抗原(PSMA)结合,PSMA是一种在前列腺癌细胞表面表达的具有良好特性的抗原。该抗原可为前列腺癌的早期活体分子成像提供一个理想的高亲和力靶点。该项目的目标是展示设计、功能化和优化用于体内靶向PSMA的金颗粒的能力,以使用光学成像技术早期发现前列腺癌。
英文摘要
Motamedi0632281The applicant proposes to enhance prostate tumor targeting by functionalizing nanogold particles with aptamers that specifically will bind to prostatic specific membrane antigen (PSMA), a well characterized antigen expressed on the surface of prostate cancer cells. This antigen could provide an ideal targeting site with high affinity for early in vivo molecular imaging of prostate cancer. The goal of the project is to demonstrate the ability to design, functionalize and optimize gold particles for in vivo targeting of PSMA for early detection of prostate cancer using optical imaging techniques.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Collaborative Research: A Point-of-Care Device for Diagnosis and Management of Pulmonary Diseases
EAGER:Nanoimaging for Molecular Diagnosis of Retina
Collaborative Research: IDR-Engineering of a Novel Nanostructure for Biomedical Sensing and Imaging
Biophotonics: Collaborative Research: Photo-activated Coupling of Nanoparticle Multilayers and Nerve Cells
海外基金